https://pressroom.prlog.org/alaxia/ About Alaxia - Development of medicinal products for respiratory diseases Meveol, 1st product existing ALAXIA’s pipeline is efficient on strong pathogens:Mucoid PAO, Burkholderia cepacia & dolosa, MRSA...even in biofilm form. Orphan Drug Designation granted EMEA FDA https://www.prlog.org/11422746-cystic-fibrosis-meveol-effective-against-burkholderia-dolosa.html The new generation of antimicrobial confirmed its potential with the evidence of effectiveness on this resistant bacterium kindly provided by Harvard Children's Hospital for which no therapeutic solution is available to dateThu, 07 Apr 2011 08:21:36 GMT